U.S. health officials are asking retailers to pull a small number of acne creams from their store shelves after government ...
Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...
The companies agreed to share profits for the therapy equally in the U.S. and Europe, but Roche will have exclusive rights to ...
Parent company La Roche-Posay has pulled the Effaclar Duo Acne Spot Treatment from L'Oreal's lineup, due to a cancer-causing ...
Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...
Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been voluntarily recalled due to elevated levels of a potentially cancer-causing agent.
Some acne treatments from brands including Walgreens, Proactiv and La-Roche Posay have been voluntarily recalled for ...
Roche is paying $1.65 billion in confirmed upfront fees to add to its burgeoning obesity pipelin | Roche is paying $1.65 ...
Some popular acne creams are being recalled because the product may contain elevated levels of benzene, a chemical that causes cancer, the FDA said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results